2019
Is PET MRI valuable in inflammation or fever of unknown aetiology?
ROHAN, Tomáš, Tomáš ANDRAŠINA, Alexandra LITAVCOVÁ, Tomáš JŮZA, Jan ZAVADIL et. al.Základní údaje
Originální název
Is PET MRI valuable in inflammation or fever of unknown aetiology?
Autoři
ROHAN, Tomáš (203 Česká republika, garant, domácí), Tomáš ANDRAŠINA (703 Slovensko, domácí), Alexandra LITAVCOVÁ (703 Slovensko, domácí), Tomáš JŮZA (203 Česká republika, domácí), Jan ZAVADIL (203 Česká republika, domácí), Svatopluk RICHTER (203 Česká republika, domácí) a Vlastimil VÁLEK (203 Česká republika)
Vydání
ECR 2019, 2019
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.579
Kód RIV
RIV/00216224:14110/19:00111855
Organizační jednotka
Lékařská fakulta
ISSN
UT WoS
000459898000001
Klíčová slova anglicky
PET/MRI; fever of unknown origin; rheumatic diseases
Štítky
Změněno: 31. 5. 2022 12:24, RNDr. Pavel Šmerk, Ph.D.
Anotace
V originále
Purpose: To evaluate the benefit of PET/MR imaging in diagnostic process of patients with inflammatory disease of unknown aetiology. Methods and Materials: 51 patients were selected for PET/MR imaging due to inflammation of unknown aetiology, these represent 2.5 % of all PET/MR examinations (total of 2056 examinations; Signa; GE) acquired in tertiary referral hospital since 7/2016. All patients underwent intensive investigation lasting at least 20 days (screening x-rays; abdominal ultrasound, dedicated CT or MRI focused in clinical suspect). Clinical (fever; artralgia; weight loss; night sweating) and laboratory (CRP, leukocytes) were monitored and correlated with PET/MR findings. Based on suspected aetiology patients were divided into 3 groups - fewer of unknown origin (26), unknown infection (13) and rheumatic disease (12). Patients were followed up until the aetiology was diagnosed or symptoms faded away. Results: In 26 (51%) patients diagnosis was proved, in 22 (43%) patients symptoms disappeared, in 3 patients symptoms persisted without explanation. PET/MR strongly supported or changed the diagnosis in 42% of cases (70% in subgroup of rheumatoid infections). As most important marker of conclusive PET/MR was shown artralgia and elevated level of CRP at the time of examination, which were present in 54% of diagnosed cases. PET/MR proved diagnosis of rheumatoid disease in 18 patients (50% without any clinical suspicion), overall sensitivity was up to 89% and specificity 100%, negative predictive value was 85%. Conclusion: PET-MRI is a useful tool in the evaluation of inflammatory disease of unknown aetiology especially in patients with suspected rheumatoid disease.
Návaznosti
MUNI/A/1574/2018, interní kód MU |
|